Momenta Pharmaceuticals, Inc. (MNTA)

[iwfal]

M402 in combination with gemcitabine almost
completely inhibited primary and metastatic tumor growth,

Sounds like a drug that will not have the typical ORR response - only a PFS type of response. Will make the ph i and ii more difficult.